Fluent

Fluent Operating Cash Flow

Delisted

The Operating Cash Flow of Fluent (TIUM.U.CN) as of Nov 5, 2026 is 18.46 M USD. In the previous year, Operating Cash Flow was 19.07 M USD — a change of -3.22% (lower).

Operating Cash Flow

18.46 MUSD

YoY

-3.22%

Last updated:

Operating Cash Flow of Fluent is 2023 18.46 M USD. Operating Cash Flow of Fluent was 2022 19.07 M USD. It decreases by -3.22% lower compared to the previous year.

The Fluent Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
-22.68 M USD
Jan 1, 2020
8.09 M USD
Jan 1, 2021
-5.03 M USD
Jan 1, 2022
19.07 M USD
Jan 1, 2023
18.46 M USD
The Fluent Operating Cash Flow history
YEAROperating Cash FlowYoY
18.46 MUSD-3.22%
19.07 MUSD-479.41%
-5.03 MUSD-162.14%
8.09 MUSD-135.66%
-22.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Operating Cash Flow of Fluent is 18.46 M USD in 2023.

Operating Cash Flow of Fluent changed from 19.07 M USD to 18.46 M USD, representing a -3.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Fluent since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Fluent historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Fluent

All Key Metrics — Fluent